Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 10, 2025, titled "Ichnos Glenmark Innovation (IGI) Announces Global Commercialization Strategy for ISB 2001 Following Licensing Deal with AbbVie".
Press Release Jul 10 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Glenmark Launches a Transformative Nutrition and Livelihood Project in Emali, Kenya
- Press Release Jun 24 2025
- Press Release Jun 09 2025
- Press Release Jun 02 2025
- Press Release May 23 2025
Later from Glenmark Pharmaceuticals
- Press Release Aug 14 2025
- Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)
- Press Release Aug 19 2025
- Q1FY 2025-26
- FY 2024-25
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals